FDA-Approved Clinical Trial to Cure Autism Begins

Researchers announced Tuesday the beginning of a FDA-approved clinical trial that uses umbilical cord blood stem cells to ‘cure’ autism.
Dr. Michael Chez, director of pediatric neurology at Sutter Neuroscience Institute in Sacramento, Calif., said he and his colleagues have been processing the trial for more than a year now, and they have high hopes it will succeed.